To examine the effects of HK2 knockdown on primary tumor growth, CFPAC-1-LUC cells containing a doxycycline-inducible shHK2#1 or shNS (control) were subcutaneously injected into immune-compromised mice. The gene discussed is HK2; the disease is neoplasm.